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Abstract
We previously found that mouse mitochondrial DNA (mtDNA) with a G13997A mutation
(G13997A mtDNA) controls not only the transformation of cultured lung carcinoma cells
from poorly metastatic into highly metastatic cells, but also the transformation of lympho-
cytes into lymphomas in living C57BL/6 (B6) mice. Because the nuclear genetic background
of the B6 strain makes the strain prone to develop lymphomas, here we examined whether
G13997A mtDNA independently induces lymphoma development even in mice with the nu-
clear genetic background of the A/J strain, which is not prone to develop lymphomas. Our
results showed that the B6 nuclear genetic background is required for frequent lymphoma
development in mice with G13997A mtDNA. Moreover, G13997A mtDNA in mice did not
enhance the malignant transformation of lung adenomas into adenocarcinomas or that
of hepatocellular carcinomas from poorly metastatic into highly metastatic carcinomas.
Therefore, G13997A mtDNA enhances the frequency of lymphoma development under the
abnormalities in the B6 nuclear genome, and does not independently control tumor devel-
opment and tumor progression.
Introduction
Mitochondrial respiration defects and the resultant enhanced glycolysis under normoxia, that
is, the Warburg effect, enable cell growth under hypoxia, and thus are thought to be involved
in tumor development [1–4]. Because pathogenic mtDNA mutations also induce mitochondri-
al respiration defects and the Warburg effect, age-associated accumulation of pathogenic
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mutations in mtDNA and the resultant age-associated expression of mitochondrial respiration
defects are considered to be responsible for tumor development [5, 6]. In fact, somatic muta-
tions are preferentially accumulated in tumor mtDNA [7–9].
In contrast, our previous studies provided convincing evidence that mtDNA with a patho-
genic G13997A mutation in the ND6 gene (G13997A mtDNA) controls the malignant trans-
formation of carcinoma cells from a poorly metastatic phenotype into a highly metastatic one
[10], although mtDNA does not control tumor development (the transformation of normal
cells into tumor cells) [10, 11]. Moreover, the induction of high metastasis was not due to respi-
ration defects and the resultant Warburg effect, but to overproduction of reactive oxygen spe-
cies (ROS) [12].
Subsequently, we generated transmitochondrial mito-mice-ND613997 (B6mtND613997) car-
rying the nuclear genome from B6 mice and G13997A mtDNA from highly metastatic carcino-
ma cells [13], and showed that they developed lymphoma with high frequency [14], indicating
the possible involvement of mtDNA mutations in tumor development. However, no tumor de-
velopment was observed in transmitochondrial mito-mice-COI6589 (B6mtCOI6589) with
T6589C mtDNA [14]. Because these mice expressed respiration defects and the Warburg effect
[15], but did not overproduce ROS, we proposed that ROS overproduction but not the War-
burg effect would be responsible for high frequency lymphoma development [14].
These findings raise several questions: Does G13997A mtDNA independently induce lym-
phomas even in mice with a nuclear genetic background that is not prone to develop lympho-
mas? Does G13997A mtDNA also induce high metastasis in tumors developed in mice, given
that it induces high metastasis in a low metastatic lung carcinoma cell line [10]? To answer
these questions, here we generated mice possessing G13997A mtDNA and nuclear genetic
background derived from the A/J strain, which is not prone to develop lymphoma [16] and
from mice that are prone to develop hepatocellular carcinomas [17, 18]. Moreover, we treated
the mice with urethane to enhance lung adenoma development [19, 20], and examined its ef-
fects on the malignant transformation of adenomas into adenocarcinomas in mice with
G13997A mtDNA.
The results suggest that G13997A mtDNA enhances the frequency of lymphoma develop-
ment that is primarily caused by abnormalities in the B6 nuclear genome. Moreover, it does
not always enhance transformation of normal cells in mice or malignant transformation of
tumor cells developed in mice, probably due to the requirement of some nuclear abnormalities.
Materials and Methods
Ethics statement
All animal experiments were performed in accordance with protocols approved by the Institu-
tional Animal Care and Use Committee of University of Tsukuba, Japan (Permit Number: 12-
264, 13-312, and 14-271).
Mice
B6 mice were purchased from CLEA Japan (Tokyo, Japan), and A/J mice were purchased
from Japan SLC (Shizuoka, Japan). Mito-miceND613997 (B6mtND613997 mice) were generated
previously [13]. Lkb1 (+/−) mice were obtained from Kyoto University. Female B6 and
B6mtND613997 mice were crossed with B6, A/J and Lkb1 (+/−) males. F1 males obtained from
the cross between B6 or B6mtND613997 females with A/J males were used for urethane treat-
ment experiments. F1 females obtained from the cross between B6 females or B6mtND6
13997
females with A/J males were furthermore backcrossed to A/J males to obtain F2 and F3
generations. F3 males were used to study the spontaneous lung tumor formation. Mice were
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monitored every day for general health, and those with signs of tumor burden, such as hunched
posture, ruffled coats, and respiratory distress, were euthanized by cervical dislocation. The
maximum tumor size (diameter) was less than 7 mm in sacrificed mice. When mice were sacri-
ficed, anesthesia with an intraperitoneal injection of 2.5% avertin was employed to minimize
animal suffering. All mice were maintained on hardwood bedding on a 12-h light/dark cycle
and given food and water ad libitum.
Measurement of ROS production in mitochondria
ROS generation was detected with the mitochondrial superoxide indicator MitoSOX-Red
(Invitrogen, Carlsbad, CA, USA). 1×105 cells were incubated with 1 mMMitoSOX-Red for 15
min at 37°C in phosphate-buffered saline (PBS), washed twice with PBS, and then immediately
analyzed with a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA). Data were
analyzed with FlowJo software (Tree Star, USA). Relative ROS levels were calculated as mean
fluorescence intensity of MitoSOX-Red stained cells minus autofluorescence of the unstained
cells.
Urethane treatment
B6 strain mice were injected intraperitoneally (IP) at 4 weeks of age with 1 mg/g body weight
urethane (ethyl carbamate; SIGMA, St. Louis, MO, USA) weekly for a total of 10 doses. Groups
of F1 hybrid mice were injected IP at 4 weeks of age with 1 mg/g body weight urethane weekly
for a total of 2 doses. Tumor multiplicities were examined 52 weeks after the initial urethane
injection.
Histological analyses
Lungs and livers were fixed in formalin solution. Tumors greater than 0.5mm in diameter on
the lung surface were counted after fixation. After overnight fixation in 10% buffered formalin,
tissues were paraffin embedded, cut into 8-μm sections, placed on glass slides, and stained with
hematoxylin and eosin. Formalin-fixed, paraffin-embedded serial sections were used for
histological analysis.
Statistical analysis
We analyzed data with the (unpaired or paired) Student t-test. Kaplan−Meier curves were as-
sessed with the log-rank test. Values with P< 0.05 were considered significant.
Results
Generation of A/J mice with G13997A mtDNA (A/JmtND613997) by
backcrossing
First, we asked whether B6 mtDNA with the G13997A mutation (G13997A mtDNA) in
B6mtND613997 mice independently regulates lymphoma development. To answer this ques-
tion, we needed to generate A/JmtND613997 mice carrying G13997A mtDNA in the nuclear ge-
netic background of the A/J strain, which is not predisposed to developing lymphoma [16].
To generate A/JmtND613997 mice, an F1 female obtained by mating a B6mtND6
13997 female
with an A/J male was backcrossed to an A/J male, and the resultant F2 females were further
backcrossed to A/J males, resulting in the generation of F3 mice (A/JmtND6
13997). A/
JmtND613997 mice thus carry a nuclear genetic background derived mostly from the A/J strain
and possess only G13997A mtDNA (Table 1). As a negative control, we generated F3 A/JmtB6
mice carrying B6 mtDNA without the G13997A mutation with a nuclear genetic background
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derived mostly from the A/J strain. A/JmtND613997 mice and A/JmtB6 mice thus share the nu-
clear and mitochondrial genetic backgrounds except that A/JmtND613997 mice carry the
G13997A mutation in mtDNA (Table 1).
Examination of tumor formation in A/JmtND613997 mice
Five A/JmtB6 males and six A/JmtND613997 males were available to investigate the effects of
the A/J nuclear genetic background on lifespan and the spectrum of tumor formation. Median
survival times of A/JmtB6 and A/JmtND613997 mice were 25.0 months and 22.0 months, re-
spectively (Fig. 1), and were similar to those observed in B6 mice (26.1 months) and
B6mtND613997 mice (24.6 months) with the B6 nuclear genetic background [14]. Thus, the life-
spans were not affected by the presence or absence of the G13997A mutation or by the differ-
ence in the nuclear genetic backgrounds.
Gross necropsy of all euthanized moribund A/JmtB6 mice and A/JmtND613997 mice showed
that no mice developed lymphomas or other tumors except pulmonary nodules, irrespective of
whether they possessed the G13997A mutation (Table 1). Given that the nuclear genetic back-
ground of the A/J strain is not prone to develop lymphoma, these data indicate that the B6 nu-
clear genetic background, which predisposes mice to develop lymphoma [16, 21–23], is
required to induce high frequency lymphoma development in B6mtND613997 mice [14]. More-
over, the G13997A mutation in mtDNA does not independently induce lymphoma develop-
ment. Thus, G13997A mtDNA simply enhances the lymphoma-prone phenotype that is
regulated by the B6 strain-derived nuclear genome. To confirm this idea, larger studies using
Table 1. Effects of nuclear-background variations and the presence or absence of B6-derived mtDNA with the G13997A mutation on the tumor-
related phenotypes of mice.
Strains No. of mice with tumors / no. of mice examined
Mice nuclear
DNA
mtDNA No. of
mice
Urethane
treatment*
Lymphoma Pulmonary
nodules
(No. of nodules)
Liver
carcinomas
Lung
metastasis
(No. of nodules)
others
B6 B6 B6 35 − 3/35** 0/35** 0/35** 0/35** 0/
35**
B6mtND613997 B6 B6
(G13997A)
35 − 16/35** 0/35** 0/35** 0/35** 0/
35**
A/JmtB6 A/J B6 5 − 0/5 4/5 (3.75 ± 0.5) 0/5 0/5 0/5
A/JmtND613997 A/J B6
(G13997A)
6 − 0/6 5/6 (3.2 ± 1.5) 0/6 0/6 0/6
B6 B6 B6 10 ++ 0/10*** 10/10 (8.0 ± 9.7) 0/10 0/10 0/10
B6mtND613997 B6 B6
(G13997A)
12 ++ 0/12*** 12/12 (7.83 ± 6.5) 0/12 0/12 0/12
B6 × A/J (F1) B6 × A/J B6 6 + 0/6 6/6 (17.3 ± 3.9) 0/6 0/6 0/6
B6mtND613997
× A/J (F1)
B6 × A/J B6
(G13997A)
5 + 0/5 5/5 (21.6 ± 8.0) 0/5 0/5 0/5
Lkb1 (+/−) B6 (Lkb1+/−) B6 19 − 0/19**** 0/19 14/19 2/14 (2.5 ± 0.7) 0/19
Lkb1 (+/−)
mtND613997
B6 (Lkb1+/−) B6
(G13997A)
16 − 0/16**** 0/16 13/16 2/13 (2 ± 0) 0/16
* B6 mice and B6mtND613997 mice sharing the B6 nuclear genetic background received weekly urethane administration for 10 times (++). In contrast, F1
hybrids between B6 females and A/J males and F1 hybrids between B6mtND6
13997 females and A/J males received weekly administration of urethane for
only twice (+) due to their higher susceptibility to urethane treatment than mice with B6 nuclear genetics background.
** These results were reported previously (Hashizume et al., 2012).
*** No mice developed lymphoma, since they were sacriﬁced to detect lung adenoma at 12 months of age.
**** No mice developed lymphoma, since they died due to the Lkb1 mutation before lymphoma development.
doi:10.1371/journal.pone.0118561.t001
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more animals than were used in this study are required, because we were unable to exclude the
possibility that there was a low level of lymphoma formation in F3 mice with the A/J nuclear
background.
We then compared ROS levels in bone marrow cells of A/JmtB6 (18-month-old male) and
A/JmtND613997 (18-month-old male) mice, using age-matched B6 males and B6mtND613997
males as controls (Fig. 2A). A/JmtND613997 mice did not show ROS overproduction (Fig. 2B),
indicating that the A/J nuclear background might possess systems to suppress ROS overpro-
duction by G13997A mtDNA. In contrast, ROS levels of B6 mice and A/JmtB6 mice were
similar (Fig. 2B), indicating that suppression of lymphoma development in A/J mice but not in
B6 mice was due to some nuclear factors in A/J mice that suppress signals of lymphoma
development.
The mice with the A/J nuclear genetic background frequently developed pulmonary nodules
(Table 1). The results were expected, because A/J mice are known to develop lung adenomas
[16]. However, the numbers of pulmonary nodules did not differ substantially between A/
JmtB6 mice and A/JmtND613997 mice (Table 1). Our histological analysis of the pulmonary
nodules suggested that they were all lung adenomas (Fig. 3). These observations indicate that
the G13997A mutation in mtDNA does not enhance either the number of lung adenomas or
the malignant progression of lung adenomas into lung adenocarcinomas in mice with the A/J
nuclear genetic background.
Effects of G13997A mtDNA on malignant progression of urethane-
induced adenomas
To further assess whether G13997A mtDNA enhances the malignant progression of lung ade-
nomas into adenocarcinomas, we treated the mice with urethane to induce early onset and en-
hance the frequency of lung adenoma development. Because F1 hybrids between B6 and A/J
mice are more susceptible to lung adenoma development than are B6 mice [19], we used six F1
hybrids between B6 females and A/J males and five F1 hybrids between B6mtND6
13997 females
and A/J males. We also used ten B6 mice and twelve B6mtND613997 mice.
Fig 1. Kaplan-Meier survival curves of A/JmtB6 and A/JmtND613997 mice.Median survival times of A/
JmtB6 mice (n = 5) and A/JmtND613997 mice (n = 6) were 25.0 months and 22.0 months, respectively. No
statistically significant differences in median survival times were observed (p = 0.2216).
doi:10.1371/journal.pone.0118561.g001
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Fig 2. Estimation of mitochondrial superoxide (i.e., reactive oxygen species, ROS) levels in bone
marrow cells after treatment with MitoSOX-Red. (A) ROS levels in bone marrow cells frommice with B6
nuclear background. (B) ROS levels in bone marrow cells frommice with A/J nuclear background. B6 mice
were used as controls. Upper panels, representative flow cytometry histograms of MitoSOX-Red. Lower
panels, relative ROS levels calculated by FlowJO as mean fluorescence intensity for MitoSOX-Red minus
background autofluorescence of the unstained cells. Data are presented as mean values with SD (n = 3).
*P< 0.05 compared with control B6 mice.
doi:10.1371/journal.pone.0118561.g002
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Based on urethane-administration protocols [19, 20], B6 mice and B6mtND613997 mice,
which share the same B6 nuclear genetic background received 10 weekly urethane injections
beginning 4 weeks after birth. In contrast, F1 hybrids between B6 females and A/J males and F1
hybrids between B6mtND613997 females and A/J males received only 2 weekly injections of ure-
thane due to their higher susceptibility to urethane treatment than that of mice with the B6 nu-
clear genetic background.
The urethane-treated mice were examined one year after the birth. All of the mice developed
pulmonary nodules, but the F1 hybrids hadmore pulmonary nodules than did mice with the B6 nu-
clear genetic background, even though the latter mice received more urethane treatments (Table 1).
There was no noteworthy difference in nodule numbers between the B6 and B6mtND613997 mice
or between the F1 hybrids with or without the G13997Amutation in their mtDNA (Table 1).
Histological analysis of the pulmonary nodules (Fig. 4) showed that they were all lung ade-
nomas: malignant progression to adenocarcinomas was not observed even in mice possessing
G13997A mtDNA (B6mtND613997 mice and F1 hybrids between B6mtND6
13997 females and
A/J males). These results demonstrate that G13997A mtDNA does not induce the tumor
Fig 3. Lung adenoma formation in A/JmtB6 and A/JmtND613997 mice.Gross necropsy (left) and
hematoxylin and eosin staining of histological sections (right) of the lung. Most mice with the A/J nuclear
genetic background developed lung adenomas. The frequencies of lung adenoma formation in A/JmtB6 and
A/JmtND613997 mice were 80% (4/5) and 83.3% (5/6), respectively. Scale bars: left, 5 mm; right, 200 μm.
doi:10.1371/journal.pone.0118561.g003
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Fig 4. Enhanced development of lung adenomas after urethane administration. Urethane-treated mice
with the nuclear genetic background of B6 (A) and of F1 hybrids between B6 and A/J mice (B). Gross
necropsy of formalin-fixed lungs (left), which were sectioned and stained with hematoxylin and eosin (right).
Small tumors (indicated by arrowheads) were observed on the surface of the lungs. Histological analysis
showed that these tumor-like abnormalities corresponded to adenomas. The numbers of lung tumors that
developed in B6, in B6mtND613997, and in F1 hybrids between B6 females × A/J males and between
B6mtND613997 females × A/J males were 8.0 ± 9.7, 7.8 ± 6.5, 17.3 ± 3.9 and 21.6 ± 8.0, respectively. Scale
bars: (A) left, 5mm; right, 100μm, (B) left, 5mm; right, 200μm.
doi:10.1371/journal.pone.0118561.g004
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progression of lung adenomas into adenocarcinomas, even when the early onset and frequency
of adenoma development are enhanced by urethane administration.
Effects of G13997A mtDNA on the metastasis of hepatocellular
carcinomas in Lkb1 (+/−) mice
Finally, we investigated whether G13997A mtDNA enhances metastasis in mice with a nuclear
abnormality that induces the development of metastasis-prone carcinomas. To this end, we
used Lkb1 (+/−) mice with the B6 nuclear genetic background to introduce G13997A mtDNA.
The Lkb1 gene is a tumor suppressor gene that plays a role in cell cycle arrest and apoptosis
[17]. Most Lkb1 (+/−) mice develop hepatocellular carcinomas within 40 weeks of birth; 10%
of them subsequently form lung metastases in the ensuing 10 weeks [18]. Our previous studies
showed that G13997A mtDNA is responsible for the high frequency of lymphoma develop-
ment in lymphoma-prone B6 mice [14] and for the high frequency of lung metastasis in metas-
tasis-prone lung carcinoma cells [10]. Therefore, we expected that G13997A mtDNA would
also induce a high frequency of lung metastasis in metastasis-prone Lkb1 (+/−) mice [18].
First, we mated B6mtND613997 females to Lkb1 (+/−) males, and obtained F1 Lkb1 (+/−)
mice possessing G13997A mtDNA (Lkb1 (+/−) mtND613997). Then, we monitored 19 male
Lkb1 (+/−) mice and 16 male Lkb1 (+/−) mtND613997 mice for signs of tumor formation. The
median survival times for the Lkb1 (+/−) mice and Lkb1 (+/−) mtND613997 mice were 14.1 and
14.0 months, respectively, and no statistically significant differences were observed between
them (Fig. 5).
Gross necropsy of all of the euthanized moribund mice showed that 14 of the 19 Lkb1 (+/−)
mice and 13 of the 16 Lkb1 (+/−) mtND613997 mice developed tumor-like abnormalities in the
liver (Table 1). Histological analysis of the liver abnormalities revealed that all of these tumor-
like abnormalities were hepatocellular carcinomas (Fig. 6A). Moreover, two of the 14 Lkb1
(+/−) mice and two of the 13 Lkb1 (+/−) mtND613997 mice that developed hepatocellular carci-
nomas had 2–3 lung nodules (Table 1, Fig. 6B). Therefore, the frequencies of lung metastasis
did not change substantially in Lkb1 (+/−) mtND613997 mice, indicating that the G13997A mu-
tation in mtDNA did not enhance lung metastasis in Lkb1 (+/−) mice.
Fig 5. Kaplan-Meier survival curves of Lkb1 (+/−) and Lkb1 (+/−) mtND613997 mice.Median survival times
of Lkb1 (+/−) (n = 19) and Lkb1 (+/−) mtND613997 mice (n = 16) were 14.1 months and 14.0 months,
respectively. No statistically significant differences in median survival times were observed between them
(p = 0.1892).
doi:10.1371/journal.pone.0118561.g005
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Fig 6. Development of tumors in the liver andmetastatic nodules in the lungs of Lkb1 (+/−) and Lkb1
(+/−) mtND613997 mice.Gross necropsy (left) and histological sections (right) of livers (A) and lungs (B).
White arrowheads indicate hepatocellular carcinomas in the liver (A) and metastatic nodules in the lung (B).
Black arrowheads on the liver sections (A) indicate the borders between the developed tumors (T) and the
G13997AmtDNA Induces Lymphoma in Mice with B6 Nuclear Background
PLOS ONE | DOI:10.1371/journal.pone.0118561 March 4, 2015 10 / 13
Discussion
The current study showed that G13997A mtDNA, which enhances lymphoma development
through ROS overproduction in B6mtND613997 mice with the B6 nuclear genetic background
[14], does not enhance lymphoma development in A/JmtND613997 mice with the A/J nuclear
genetic background, which is not prone to lymphoma development (Table 1). Thus, G13997A
mtDNA regulates lymphoma development with the help of the B6 nuclear background. At this
time, we do not know what factors in B6 mice help the lymphoma development. To identify
the nuclear factors that are involved in lymphoma development in B6 mice, it would be helpful
to isolate two B6 sublines that show low and high frequency of lymphoma development, re-
spectively, and to compare their whole nuclear genome sequences.
With respect to the malignant transformation of tumors, G13997A mtDNA, which en-
hanced the lung metastasis of a lung carcinoma cell line [10], neither induced malignant trans-
formation of lung adenomas nor enhanced the lung metastasis of hepatocellular carcinomas
(Table 1). Therefore, G13997A mtDNA does not independently enhance transformation of
normal cells (tumor development) or malignant transformation of tumor cells, probably due to
the requirement of some nuclear abnormalities.
Our previous study [15] revealed that B6mtCOI6589 mice, which have the B6 nuclear genetic
background and carry homoplasmic T6589C mtDNA in their COI gene, exhibited a low fre-
quency of lymphoma development, probably due to the expression of respiration defects in the
absence of ROS overproduction. Therefore, the B6 nuclear genetic background as well as
mtDNA mutations that induce ROS overproduction appears to be required for a high frequen-
cy of lymphoma development in mice.
It has been proposed that accumulation of pathogenic mtDNA mutations and the resultant
Warburg effect enhance cell growth under conditions of hypoxia, and thus are involved in
tumor development [1–4]. To further assess the idea, we have to generate additional transmito-
chondrial mice carrying various nuclear genetic abnormalities or mtDNA with various patho-
genic mutations that induce respiration defects and/or ROS overproduction. Recently, we
generated transmitochondrial mice (B6mtRNALys7731) with the B6 nuclear genetic background
and high proportions of mtDNA containing the G7731A mutation in their tRNALys gene [24].
Because G7731A mtDNA simultaneously induces mitochondrial respiration defects and mod-
est ROS overproduction [24], and ROS overproduction has been linked to heart failure [25],
we plan to examine whether these mice will show a high frequency of lymphoma development
or heart failure as they age.
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